CX3CL1 expression correlates with CD8+ and CD57+ cell infiltrations. Tumor stage (I/II versus III), HER-2 status and CX3CL1 expression were independent prognostic factors for disease-free and overall survival. This evidence concerns the gene CD8A and neoplasm.